指南与共识心血管US

无症状主动脉瓣反流早期左心室功能障碍的超声心动图标志物:是时候改变指南了吗?

Echocardiographic Markers of Early Left Ventricular Dysfunction in Asymptomatic Aortic Regurgitation: Is It Time to Change the Guidelines?
指南 / 共识 · JACC Cardiovasc Imaging · 2024-11-13

该研究回顾性分析673例无症状慢性中重度以上主动脉瓣反流患者,评估左心室射血分数<60%、左心室收缩末期容积指数≥45 mL/m2及整体纵向应变差于-15%与全因死亡的关系,并与美国心脏病学会/美国心脏协会指南I/IIa类推荐比较。结果显示达到指南I/IIa类推荐时死亡风险最高(HR 4.22),无指南推荐时存在至少2个早期左心室功能障碍标志物者死亡风险升高。

要点

  • 无症状慢性显著主动脉瓣反流患者达到指南I/IIa类手术推荐时监测期死亡风险显著升高(HR 4.22)。
  • 无指南I/IIa类推荐时,存在至少2个早期左心室功能障碍标志物者死亡风险更高。
  • 左心室射血分数<60%与死亡的关联最强,统计学上略优于整体纵向应变和收缩末期容积指数。

核心结论

  • 无症状临床显著慢性主动脉瓣反流患者达到美国心脏病学会/美国心脏协会指南I/IIa类推荐时存在生存惩罚;无这些推荐时,至少2个早期左心室功能障碍标志物可识别死亡风险更高、可能从早期手术获益的患者。

研究设计与样本

  • 回顾性分析2004至2019年单中心673例无症状慢性临床显著(≥中重度)主动脉瓣反流患者,主要结局为全因死亡。

诊断标准与关键数值

  • 左心室射血分数<60%见于296例(44%)患者。
  • 整体纵向应变差于-15%见于482例中的122例(25%)。
  • 左心室收缩末期容积指数≥45 mL/m2见于261例(39%)患者。
  • 监测期死亡率在存在指南I/IIa类推荐时最高(HR 4.22;95%CI 2.15-8.29),其次为存在1个以上早期左心室功能障碍标志物(HR 2.18;95%CI 1.21-3.92),以无标志物为参照(均P<0.05)。
  • 无指南I/IIa类推荐时,1个早期左心室功能障碍标志物与无标志物相比死亡率更高但未达统计学显著(P=0.063),2个标志物次之;3个标志物均存在时死亡率最高(HR 5.46;95%CI 2.51-11.90;P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The ideal timing for surgery in asymptomatic chronic aortic regurgitation (AR) remains unclear. New thresholds for left ventricular ejection fraction (LVEF), left ventricular (LV) indexed end-systolic volume (iESV), and global longitudinal strain (GLS) have been associated with mortality in these patients. These represent markers of early LV dysfunction.

OBJECTIVES: The authors sought to assess the relationship between these markers (LVEF <60%, iESV ≥45 mL/m2, and GLS worse than -15%) and mortality, comparing them to Class I/IIa American College of Cardiology/American Heart Association guideline recommendations and absence of any of these.

METHODS: A total of 673 asymptomatic patients with chronic clinically significant (≥ moderate-severe) AR between 2004 and 2019 at a single referral center were retrospectively analyzed. The primary study outcome was all-cause mortality.

RESULTS: Mean age was 57 ± 17 years, 97 (14%) were female, 293 (45%) had hypertension, and 273 (41%) had an abnormal number of valve cusps. Aortic valve replacement was performed in 281 (48%) patients, and 69 (10%) died while under surveillance (without aortic valve replacement). LVEF <60% was present in 296 (44%) patients, 122 (25%) of 482 had GLS worse than -15%, and 261 (39%) had iESV ≥45 mL/m2. Mortality under surveillance was highest when Class I/IIa recommendations were present (HR: 4.22; 95% CI: 2.15-8.29), followed by the presence of 1 or more markers of early LV dysfunction (HR: 2.18; 95% CI: 1.21-3.92); no markers was used as the reference (all, P < 0.05). LVEF showed the strongest association with mortality, statistically slightly better than GLS and iESV. In the absence of Class I/IIa recommendations, 1 marker of early LV dysfunction was associated with higher, although not statistically significant, mortality compared with no markers (P = 0.063), followed by 2 markers; highest mortality was when all 3 markers were present (HR: 5.46 [95% CI: 2.51-11.90]; P < 0.001).

CONCLUSIONS: Patients with asymptomatic clinically significant chronic AR incur a survival penalty when Class I/IIa guideline recommendations are attained. In patients without these recommendations, at least 2 markers of early LV dysfunction identify those with higher mortality risk who may benefit from early surgery.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Anand V, Michelena HI, Scott CG, et al. Echocardiographic Markers of Early Left Ventricular Dysfunction in Asymptomatic Aortic Regurgitation: Is It Time to Change the Guidelines? JACC Cardiovasc Imaging. 2024. PMID: 39545891. doi:10.1016/j.jcmg.2024.09.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。